Kiniksa Pharmaceuticals Ltd. (KNSA) NASDAQ
$19.73 (0.26) (-1.30%)
Market Cap: $788.81M
As of 03/28/24 04:00 PM EDT. Market closed.
Kiniksa Pharmaceuticals Ltd. (KNSA)
NASDAQ
$19.73
(0.26) (-1.30%)
Market Cap: $788.81M
As of 03/28/24 04:00 PM EDT. Market closed.
kiniksa pharmaceuticals combines an experienced management team and significant committed capital in order to acquire, develop, and commercialize therapeutics treating devastating diseases with high unmet ... read more
kiniksa pharmaceuticals combines an experienced management team and significant committed capital in order to acquire, develop, and commercialize therapeutics treating devastating diseases with high unmet needs. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Patel Sanj K | CHAIRMAN & CEO | Mar 07, 2024 | Sale | $21.02 | 65,012 | 1,366,552 | 0 | Mar 11, 2024, 07:05 PM |
Patel Sanj K | CHAIRMAN & CEO | Mar 06, 2024 | Sale | $21.00 | 5,582 | 117,222 | 65,012 | Mar 06, 2024, 05:37 PM |
Patel Sanj K | CHAIRMAN & CEO | Mar 04, 2024 | Sale | $21.49 | 12,742 | 273,834 | 73,930 | Mar 06, 2024, 05:37 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Mar 01, 2024 | Option Exercise | $1.59 | 656 | 1,043 | 124,036 | Mar 05, 2024, 04:34 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Mar 01, 2024 | Sale | $22.03 | 1,189 | 26,194 | 122,847 | Mar 05, 2024, 04:34 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Jan 15, 2024 | Option Exercise | $12.35 | 583 | 7,200 | 17,588 | Mar 01, 2024, 06:26 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 01, 2024 | Option Exercise | $10.93 | 9,659 | 105,560 | 27,247 | Mar 01, 2024, 06:26 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Feb 28, 2024 | Option Exercise | $8.83 | 5,126 | 45,263 | 22,714 | Mar 01, 2024, 06:26 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 01, 2024 | Sale | $21.45 | 9,659 | 207,186 | 17,588 | Mar 01, 2024, 06:26 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Feb 28, 2024 | Sale | $21.79 | 5,126 | 111,696 | 17,588 | Mar 01, 2024, 06:26 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Feb 27, 2024 | Option Exercise | $1.86 | 10,156 | 18,890 | 55,048 | Feb 29, 2024, 04:26 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Feb 27, 2024 | Sale | $21.03 | 10,156 | 213,581 | 44,892 | Feb 29, 2024, 04:26 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Jan 03, 2024 | Option Exercise | $8.83 | 12,000 | 105,960 | 27,632 | Jan 04, 2024, 04:30 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Jan 03, 2024 | Sale | $20.00 | 12,000 | 240,000 | 15,632 | Jan 04, 2024, 04:30 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Dec 19, 2023 | Option Exercise | $13.88 | 9,316 | 129,306 | 26,321 | Dec 21, 2023, 04:26 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Dec 19, 2023 | Sale | $19.13 | 9,316 | 178,215 | 17,005 | Dec 21, 2023, 04:26 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Dec 07, 2023 | Option Exercise | $1.86 | 28,600 | 53,196 | 73,492 | Dec 11, 2023, 04:20 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Dec 07, 2023 | Sale | $17.65 | 28,600 | 504,758 | 66,112 | Dec 11, 2023, 04:20 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Oct 04, 2023 | Option Exercise | $16.01 | 52 | 833 | 17,005 | Oct 06, 2023, 04:26 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Jul 15, 2023 | Option Exercise | $12.35 | 581 | 7,175 | 13,558 | Sep 06, 2023, 07:08 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 228 | 4,049 | 16,882 | Sep 06, 2023, 07:08 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 1,155 | 20,513 | 16,336 | Sep 06, 2023, 07:08 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Jul 15, 2023 | Option Exercise | $12.35 | 292 | 3,606 | 12,845 | Sep 06, 2023, 07:07 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 543 | 9,644 | 14,420 | Sep 06, 2023, 07:07 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 1,353 | 24,029 | 13,969 | Sep 06, 2023, 07:07 PM |
Patel Sanj K | CHAIRMAN & CEO | Sep 02, 2023 | Option Exercise | $17.76 | 2,187 | 38,841 | 52,516 | Sep 06, 2023, 07:06 PM |
Patel Sanj K | CHAIRMAN & CEO | Sep 01, 2023 | Option Exercise | $17.76 | 4,432 | 78,712 | 48,134 | Sep 06, 2023, 07:06 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 547 | 9,715 | 15,632 | Sep 06, 2023, 07:06 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 791 | 14,048 | 14,318 | Sep 06, 2023, 07:06 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 577 | 10,248 | 123,380 | Sep 06, 2023, 07:04 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 801 | 14,226 | 121,993 | Sep 06, 2023, 07:04 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 507 | 9,004 | 44,892 | Sep 06, 2023, 07:03 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 734 | 13,036 | 43,674 | Sep 06, 2023, 07:03 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Sep 05, 2023 | Option Exercise | $1.86 | 400 | 744 | 45,292 | Sep 06, 2023, 07:03 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Sep 05, 2023 | Sale | $17.53 | 400 | 7,012 | 44,892 | Sep 06, 2023, 07:03 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Jul 25, 2023 | Option Exercise | $1.86 | 29,000 | 53,940 | 70,910 | Jul 27, 2023, 04:30 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Jul 25, 2023 | Sale | $19.14 | 29,000 | 555,160 | 65,710 | Jul 27, 2023, 04:30 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 26, 2023 | Option Exercise | $11.15 | 291 | 3,245 | 12,414 | Apr 28, 2023, 04:15 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 1,155 | 12,370 | 12,977 | Apr 11, 2023, 05:07 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 1,353 | 14,491 | 12,553 | Apr 11, 2023, 05:06 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 734 | 7,861 | 41,910 | Apr 11, 2023, 05:06 PM |
Patel Sanj K | CHAIRMAN & CEO | Apr 10, 2023 | Option Exercise | $10.71 | 2,933 | 31,412 | 42,574 | Apr 11, 2023, 05:05 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 791 | 8,472 | 11,715 | Apr 11, 2023, 05:04 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 801 | 8,579 | 120,067 | Apr 11, 2023, 05:03 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 1,078 | 11,987 | 40,146 | Mar 20, 2023, 05:20 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 507 | 5,810 | 37,553 | Mar 20, 2023, 05:20 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Jan 15, 2023 | Option Exercise | $9.56 | 1,844 | 17,629 | 10,008 | Mar 20, 2023, 05:19 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 1,167 | 12,977 | 11,429 | Mar 20, 2023, 05:19 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 543 | 6,223 | 10,459 | Mar 20, 2023, 05:19 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Jan 15, 2023 | Option Exercise | $9.56 | 704 | 6,730 | 8,118 | Mar 20, 2023, 05:18 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 221 | 2,533 | 8,671 | Mar 20, 2023, 05:18 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 635 | 7,061 | 10,199 | Mar 20, 2023, 05:18 PM |
Patel Sanj K | CHAIRMAN & CEO | Mar 20, 2023 | Option Exercise | $11.12 | 3,523 | 39,176 | 35,515 | Mar 20, 2023, 05:16 PM |
Patel Sanj K | CHAIRMAN & CEO | Mar 16, 2023 | Option Exercise | $11.46 | 1,929 | 22,106 | 27,036 | Mar 20, 2023, 05:16 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 876 | 9,741 | 118,141 | Mar 20, 2023, 05:15 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 577 | 6,612 | 116,035 | Mar 20, 2023, 05:15 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 634 | 7,050 | 9,811 | Mar 20, 2023, 05:14 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 256 | 2,934 | 8,287 | Mar 20, 2023, 05:14 PM |
Quart Barry D | Director | Nov 29, 2022 | Option Exercise | $1.59 | 21,959 | 34,915 | 21,959 | Dec 01, 2022, 04:16 PM |
Quart Barry D | Director | Nov 29, 2022 | Sale | $16.15 | 21,959 | 354,638 | 0 | Dec 01, 2022, 04:16 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Nov 07, 2022 | Option Exercise | $1.86 | 28,357 | 52,744 | 64,692 | Nov 09, 2022, 04:16 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Nov 07, 2022 | Sale | $15.18 | 28,357 | 430,459 | 36,335 | Nov 09, 2022, 04:16 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Oct 04, 2022 | Option Exercise | $14.23 | 52 | 740 | 7,414 | Oct 06, 2022, 04:18 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Jul 15, 2022 | Option Exercise | $9.56 | 360 | 3,442 | 7,732 | Sep 06, 2022, 04:12 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 563 | 6,441 | 8,164 | Sep 06, 2022, 04:12 PM |
Patel Sanj K | CHAIRMAN & CEO | Sep 02, 2022 | Option Exercise | $11.44 | 1,929 | 22,068 | 22,396 | Sep 06, 2022, 04:11 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 507 | 5,800 | 36,335 | Sep 06, 2022, 04:10 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 547 | 6,258 | 7,671 | Sep 06, 2022, 04:10 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Jul 15, 2022 | Option Exercise | $9.56 | 1,048 | 10,019 | 113,261 | Sep 06, 2022, 04:09 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 577 | 6,601 | 114,648 | Sep 06, 2022, 04:09 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Jul 15, 2022 | Option Exercise | $9.56 | 703 | 6,721 | 6,744 | Sep 06, 2022, 04:08 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 228 | 2,608 | 7,291 | Sep 06, 2022, 04:08 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 26, 2022 | Option Exercise | $9.99 | 282 | 2,817 | 6,357 | Apr 28, 2022, 04:31 PM |
Patel Sanj K | CHAIRMAN & CEO | Mar 21, 2022 | Option Exercise | $10.98 | 5,446 | 59,797 | 17,756 | Mar 23, 2022, 04:30 PM |
Moat Ross | CHIEF COMMERCIAL OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,240 | 13,615 | 7,372 | Mar 23, 2022, 04:30 PM |
Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,047 | 11,496 | 5,648 | Mar 23, 2022, 04:30 PM |
Paolini John F. | CHIEF MEDICAL OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,686 | 18,512 | 35,117 | Mar 23, 2022, 04:30 PM |
Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,120 | 12,298 | 6,041 | Mar 23, 2022, 04:30 PM |
Tessari Eben | CHIEF OPERATING OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,461 | 16,042 | 112,213 | Mar 23, 2022, 04:30 PM |
Megna Michael R | Chief Accounting Officer | Jan 15, 2022 | Option Exercise | $9.63 | 653 | 6,288 | 3,424 | Mar 18, 2022, 04:40 PM |
Megna Michael R | Chief Accounting Officer | Jul 15, 2021 | Option Exercise | $11.49 | 588 | 6,756 | 2,771 | Mar 18, 2022, 04:40 PM |
Megna Michael R | Chief Accounting Officer | Dec 31, 2020 | Option Exercise | $15.02 | 405 | 6,083 | 2,183 | Mar 18, 2022, 04:40 PM |
Megna Michael R | Chief Accounting Officer | Jun 30, 2020 | Option Exercise | $9.51 | 641 | 6,096 | 1,778 | Mar 18, 2022, 04:40 PM |
Megna Michael R | Chief Accounting Officer | Mar 16, 2022 | Option Exercise | $10.13 | 269 | 2,725 | 3,930 | Mar 18, 2022, 04:40 PM |
Moat Ross | Chief Commercial Officer | Jul 15, 2021 | Option Exercise | $11.49 | 963 | 11,065 | 4,345 | Mar 18, 2022, 04:39 PM |
Moat Ross | Chief Commercial Officer | Jan 15, 2022 | Option Exercise | $9.63 | 1,546 | 14,888 | 5,891 | Mar 18, 2022, 04:39 PM |
Moat Ross | Chief Commercial Officer | Mar 16, 2022 | Option Exercise | $10.13 | 544 | 5,511 | 6,342 | Mar 18, 2022, 04:39 PM |
Paolini John F. | Chief Medical Officer | Mar 16, 2022 | Option Exercise | $10.13 | 598 | 6,058 | 31,127 | Mar 18, 2022, 04:39 PM |
Patel Sanj K | Chairman & CEO | Mar 16, 2022 | Option Exercise | $10.13 | 1,922 | 19,470 | 4,647 | Mar 18, 2022, 04:38 PM |
Ragosa Mark | Chief Financial Officer | Mar 16, 2022 | Option Exercise | $10.13 | 303 | 3,069 | 3,676 | Mar 18, 2022, 04:38 PM |
Tessari Eben | Chief Operating Officer | Jan 15, 2022 | Option Exercise | $9.63 | 970 | 9,341 | 107,780 | Mar 18, 2022, 04:36 PM |
Tessari Eben | Chief Operating Officer | Jul 15, 2021 | Option Exercise | $11.49 | 868 | 9,973 | 106,810 | Mar 18, 2022, 04:36 PM |
Tessari Eben | Chief Operating Officer | Mar 16, 2022 | Option Exercise | $10.13 | 681 | 6,899 | 109,063 | Mar 18, 2022, 04:36 PM |
Patel Sanj K | Chairman & CEO | Feb 09, 2021 | Option Exercise | $1.59 | 20,401 | 32,438 | 20,401 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 08, 2021 | Option Exercise | $1.59 | 4,924 | 7,829 | 4,924 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 10, 2021 | Option Exercise | $1.59 | 1,600 | 2,544 | 1,600 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 09, 2021 | Sale | $23.08 | 23,569 | 543,973 | 84,473 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 08, 2021 | Sale | $23.00 | 4,528 | 104,144 | 108,042 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 09, 2021 | Sale | $23.04 | 20,401 | 470,039 | 0 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 10, 2021 | Sale | $23.07 | 1,137 | 26,231 | 83,336 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 08, 2021 | Sale | $23.00 | 4,924 | 113,252 | 0 | Feb 10, 2021, 07:07 PM |
Patel Sanj K | Chairman & CEO | Feb 10, 2021 | Sale | $23.06 | 1,600 | 36,896 | 0 | Feb 10, 2021, 07:07 PM |
Beetham Thomas W. | EVP & Chief Legal Officer | Feb 03, 2021 | Sale | $22.09 | 2,477 | 54,717 | 297,523 | Feb 05, 2021, 06:55 PM |
Ragosa Mark | Interim CFO | Dec 31, 2020 | Option Exercise | $17.67 | 1,297 | 22,918 | 3,107 | Jan 05, 2021, 05:07 PM |
Rizvi Qasim | Chief Commercial Officer | Dec 31, 2020 | Option Exercise | $17.67 | 2,161 | 38,185 | 5,176 | Jan 05, 2021, 05:07 PM |
Patel Sanj K | Chairman & CEO | Oct 09, 2020 | Option Exercise | $1.59 | 872 | 1,386 | 872 | Oct 14, 2020, 05:22 PM |
Patel Sanj K | Chairman & CEO | Oct 12, 2020 | Option Exercise | $1.59 | 150,700 | 239,613 | 150,700 | Oct 14, 2020, 05:22 PM |
Patel Sanj K | Chairman & CEO | Oct 09, 2020 | Sale | $21.00 | 670 | 14,070 | 211,900 | Oct 14, 2020, 05:22 PM |
Patel Sanj K | Chairman & CEO | Oct 09, 2020 | Sale | $21.00 | 872 | 18,312 | 0 | Oct 14, 2020, 05:22 PM |
Patel Sanj K | Chairman & CEO | Oct 12, 2020 | Sale | $21.02 | 99,330 | 2,087,917 | 112,570 | Oct 14, 2020, 05:22 PM |
Patel Sanj K | Chairman & CEO | Oct 12, 2020 | Sale | $21.02 | 150,700 | 3,167,714 | 0 | Oct 14, 2020, 05:22 PM |
Beetham Thomas W. | EVP & Chief Legal Officer | Jul 01, 2020 | Sale | $25.37 | 29,589 | 750,678 | 2,855 | Jul 02, 2020, 04:13 PM |
Beetham Thomas W. | EVP & Chief Legal Officer | Jun 10, 2020 | Option Exercise | $1.59 | 13,752 | 21,866 | 43,341 | Jun 12, 2020, 05:50 PM |
Beetham Thomas W. | EVP & Chief Legal Officer | Jun 10, 2020 | Sale | $25.07 | 13,752 | 344,763 | 29,589 | Jun 12, 2020, 05:50 PM |
Beetham Thomas W. | EVP & Chief Legal Officer | Apr 20, 2020 | Sale | $19.06 | 47,423 | 903,882 | 32,107 | Apr 22, 2020, 05:39 PM |
Beetham Thomas W. | EVP & Chief Legal Officer | Apr 21, 2020 | Sale | $19.89 | 2,518 | 50,092 | 30,544 | Apr 22, 2020, 05:39 PM |
Patel Sanj K | Chairman & CEO | Mar 06, 2020 | Sale | $20.00 | 33,115 | 662,300 | 212,570 | Mar 10, 2020, 05:33 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 27, 2020 | Option Exercise | $1.86 | 12,000 | 22,320 | 30,000 | Mar 02, 2020, 05:48 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 19, 2020 | Option Exercise | $3.80 | 22,477 | 85,413 | 40,477 | Feb 21, 2020, 04:57 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 20, 2020 | Option Exercise | $3.80 | 9,803 | 37,251 | 27,803 | Feb 21, 2020, 04:57 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 20, 2020 | Sale | $18.96 | 9,803 | 185,832 | 19,116 | Feb 21, 2020, 04:57 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 19, 2020 | Sale | $18.27 | 22,477 | 410,655 | 18,000 | Feb 21, 2020, 04:57 PM |
Beetham Thomas W. | EVP & Chief Legal Officer | Feb 14, 2020 | Sale | $18.58 | 59 | 1,096 | 79,530 | Feb 19, 2020, 05:24 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 14, 2020 | Option Exercise | $3.80 | 1,039 | 3,948 | 19,039 | Feb 18, 2020, 06:05 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 13, 2020 | Option Exercise | $3.80 | 10,277 | 39,053 | 28,277 | Feb 18, 2020, 06:05 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 14, 2020 | Sale | $18.33 | 1,039 | 19,045 | 18,000 | Feb 18, 2020, 06:05 PM |
Paolini John F. | SVP & Chief Medical Officer | Feb 13, 2020 | Sale | $18.29 | 10,277 | 187,966 | 18,000 | Feb 18, 2020, 06:05 PM |
Paolini John F. | SVP & Chief Medical Officer | Dec 05, 2019 | Option Exercise | $1.86 | 8,000 | 14,880 | 8,000 | Dec 09, 2019, 05:57 PM |
Paolini John F. | SVP & Chief Medical Officer | Oct 07, 2019 | Option Exercise | $1.86 | 10,000 | 18,600 | 10,000 | Oct 09, 2019, 04:15 PM |
Flynn James E | 10% Owner | May 29, 2018 | Buy | $18.97 | 843,352 | 15,996,834 | 843,352 | May 31, 2018, 04:19 PM |
Cormorant Asset Management, LP | 10% Owner | May 29, 2018 | Buy | $18.00 | 69,444 | 1,249,992 | 900,443 | May 31, 2018, 04:13 PM |
BAKER BROS. ADVISORS LP | Director | May 29, 2018 | Buy | $18.00 | 3,000,000 | 54,000,000 | 2,700,597 | May 31, 2018, 04:10 PM |
Owner | Relationship | Date | Value($) |
Patel Sanj K | CHAIRMAN & CEO | 03/07/2024 | 1,366,552 |
Patel Sanj K | CHAIRMAN & CEO | 03/06/2024 | 117,222 |
Patel Sanj K | CHAIRMAN & CEO | 03/04/2024 | 273,834 |
Tessari Eben | CHIEF OPERATING OFFICER | 03/01/2024 | 1,043 |
Tessari Eben | CHIEF OPERATING OFFICER | 03/01/2024 | 26,194 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 01/15/2024 | 7,200 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 03/01/2024 | 105,560 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 02/28/2024 | 45,263 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 03/01/2024 | 207,186 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 02/28/2024 | 111,696 |
Paolini John F. | CHIEF MEDICAL OFFICER | 02/27/2024 | 18,890 |
Paolini John F. | CHIEF MEDICAL OFFICER | 02/27/2024 | 213,581 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 01/03/2024 | 105,960 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 01/03/2024 | 240,000 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 12/19/2023 | 129,306 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 12/19/2023 | 178,215 |
Paolini John F. | CHIEF MEDICAL OFFICER | 12/07/2023 | 53,196 |
Paolini John F. | CHIEF MEDICAL OFFICER | 12/07/2023 | 504,758 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 10/04/2023 | 833 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 07/15/2023 | 7,175 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 09/02/2023 | 4,049 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 09/01/2023 | 20,513 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 07/15/2023 | 3,606 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 09/02/2023 | 9,644 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 09/01/2023 | 24,029 |
Patel Sanj K | CHAIRMAN & CEO | 09/02/2023 | 38,841 |
Patel Sanj K | CHAIRMAN & CEO | 09/01/2023 | 78,712 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 09/02/2023 | 9,715 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 09/01/2023 | 14,048 |
Tessari Eben | CHIEF OPERATING OFFICER | 09/02/2023 | 10,248 |
Tessari Eben | CHIEF OPERATING OFFICER | 09/01/2023 | 14,226 |
Paolini John F. | CHIEF MEDICAL OFFICER | 09/02/2023 | 9,004 |
Paolini John F. | CHIEF MEDICAL OFFICER | 09/01/2023 | 13,036 |
Paolini John F. | CHIEF MEDICAL OFFICER | 09/05/2023 | 744 |
Paolini John F. | CHIEF MEDICAL OFFICER | 09/05/2023 | 7,012 |
Paolini John F. | CHIEF MEDICAL OFFICER | 07/25/2023 | 53,940 |
Paolini John F. | CHIEF MEDICAL OFFICER | 07/25/2023 | 555,160 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 04/26/2023 | 3,245 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 04/10/2023 | 12,370 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 04/10/2023 | 14,491 |
Paolini John F. | CHIEF MEDICAL OFFICER | 04/10/2023 | 7,861 |
Patel Sanj K | CHAIRMAN & CEO | 04/10/2023 | 31,412 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 04/10/2023 | 8,472 |
Tessari Eben | CHIEF OPERATING OFFICER | 04/10/2023 | 8,579 |
Paolini John F. | CHIEF MEDICAL OFFICER | 03/20/2023 | 11,987 |
Paolini John F. | CHIEF MEDICAL OFFICER | 03/16/2023 | 5,810 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 01/15/2023 | 17,629 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 03/20/2023 | 12,977 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 03/16/2023 | 6,223 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 01/15/2023 | 6,730 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 03/16/2023 | 2,533 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 03/20/2023 | 7,061 |
Patel Sanj K | CHAIRMAN & CEO | 03/20/2023 | 39,176 |
Patel Sanj K | CHAIRMAN & CEO | 03/16/2023 | 22,106 |
Tessari Eben | CHIEF OPERATING OFFICER | 03/20/2023 | 9,741 |
Tessari Eben | CHIEF OPERATING OFFICER | 03/16/2023 | 6,612 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 03/20/2023 | 7,050 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 03/16/2023 | 2,934 |
Quart Barry D | Director | 11/29/2022 | 34,915 |
Quart Barry D | Director | 11/29/2022 | 354,638 |
Paolini John F. | CHIEF MEDICAL OFFICER | 11/07/2022 | 52,744 |
Paolini John F. | CHIEF MEDICAL OFFICER | 11/07/2022 | 430,459 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 10/04/2022 | 740 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 07/15/2022 | 3,442 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 09/02/2022 | 6,441 |
Patel Sanj K | CHAIRMAN & CEO | 09/02/2022 | 22,068 |
Paolini John F. | CHIEF MEDICAL OFFICER | 09/02/2022 | 5,800 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 09/02/2022 | 6,258 |
Tessari Eben | CHIEF OPERATING OFFICER | 07/15/2022 | 10,019 |
Tessari Eben | CHIEF OPERATING OFFICER | 09/02/2022 | 6,601 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 07/15/2022 | 6,721 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 09/02/2022 | 2,608 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 04/26/2022 | 2,817 |
Patel Sanj K | CHAIRMAN & CEO | 03/21/2022 | 59,797 |
Moat Ross | CHIEF COMMERCIAL OFFICER | 03/21/2022 | 13,615 |
Ragosa Mark | CHIEF FINANCIAL OFFICER | 03/21/2022 | 11,496 |
Paolini John F. | CHIEF MEDICAL OFFICER | 03/21/2022 | 18,512 |
Megna Michael R | CHIEF ACCOUNTING OFFICER | 03/21/2022 | 12,298 |
Tessari Eben | CHIEF OPERATING OFFICER | 03/21/2022 | 16,042 |
Megna Michael R | Chief Accounting Officer | 01/15/2022 | 6,288 |
Megna Michael R | Chief Accounting Officer | 07/15/2021 | 6,756 |
Megna Michael R | Chief Accounting Officer | 12/31/2020 | 6,083 |
Megna Michael R | Chief Accounting Officer | 06/30/2020 | 6,096 |
Megna Michael R | Chief Accounting Officer | 03/16/2022 | 2,725 |
Moat Ross | Chief Commercial Officer | 07/15/2021 | 11,065 |
Moat Ross | Chief Commercial Officer | 01/15/2022 | 14,888 |
Moat Ross | Chief Commercial Officer | 03/16/2022 | 5,511 |
Paolini John F. | Chief Medical Officer | 03/16/2022 | 6,058 |
Patel Sanj K | Chairman & CEO | 03/16/2022 | 19,470 |
Ragosa Mark | Chief Financial Officer | 03/16/2022 | 3,069 |
Tessari Eben | Chief Operating Officer | 01/15/2022 | 9,341 |
Tessari Eben | Chief Operating Officer | 07/15/2021 | 9,973 |
Tessari Eben | Chief Operating Officer | 03/16/2022 | 6,899 |
Patel Sanj K | Chairman & CEO | 02/09/2021 | 32,438 |
Patel Sanj K | Chairman & CEO | 02/08/2021 | 7,829 |
Patel Sanj K | Chairman & CEO | 02/10/2021 | 2,544 |
Patel Sanj K | Chairman & CEO | 02/09/2021 | 543,973 |
Patel Sanj K | Chairman & CEO | 02/08/2021 | 104,144 |
Patel Sanj K | Chairman & CEO | 02/09/2021 | 470,039 |
Patel Sanj K | Chairman & CEO | 02/10/2021 | 26,231 |
Patel Sanj K | Chairman & CEO | 02/08/2021 | 113,252 |
Patel Sanj K | Chairman & CEO | 02/10/2021 | 36,896 |
Beetham Thomas W. | EVP & Chief Legal Officer | 02/03/2021 | 54,717 |
Ragosa Mark | Interim CFO | 12/31/2020 | 22,918 |
Rizvi Qasim | Chief Commercial Officer | 12/31/2020 | 38,185 |
Patel Sanj K | Chairman & CEO | 10/09/2020 | 1,386 |
Patel Sanj K | Chairman & CEO | 10/12/2020 | 239,613 |
Patel Sanj K | Chairman & CEO | 10/09/2020 | 14,070 |
Patel Sanj K | Chairman & CEO | 10/09/2020 | 18,312 |
Patel Sanj K | Chairman & CEO | 10/12/2020 | 2,087,917 |
Patel Sanj K | Chairman & CEO | 10/12/2020 | 3,167,714 |
Beetham Thomas W. | EVP & Chief Legal Officer | 07/01/2020 | 750,678 |
Beetham Thomas W. | EVP & Chief Legal Officer | 06/10/2020 | 21,866 |
Beetham Thomas W. | EVP & Chief Legal Officer | 06/10/2020 | 344,763 |
Beetham Thomas W. | EVP & Chief Legal Officer | 04/20/2020 | 903,882 |
Beetham Thomas W. | EVP & Chief Legal Officer | 04/21/2020 | 50,092 |
Patel Sanj K | Chairman & CEO | 03/06/2020 | 662,300 |
Paolini John F. | SVP & Chief Medical Officer | 02/27/2020 | 22,320 |
Paolini John F. | SVP & Chief Medical Officer | 02/19/2020 | 85,413 |
Paolini John F. | SVP & Chief Medical Officer | 02/20/2020 | 37,251 |
Paolini John F. | SVP & Chief Medical Officer | 02/20/2020 | 185,832 |
Paolini John F. | SVP & Chief Medical Officer | 02/19/2020 | 410,655 |
Beetham Thomas W. | EVP & Chief Legal Officer | 02/14/2020 | 1,096 |
Paolini John F. | SVP & Chief Medical Officer | 02/14/2020 | 3,948 |
Paolini John F. | SVP & Chief Medical Officer | 02/13/2020 | 39,053 |
Paolini John F. | SVP & Chief Medical Officer | 02/14/2020 | 19,045 |
Paolini John F. | SVP & Chief Medical Officer | 02/13/2020 | 187,966 |
Paolini John F. | SVP & Chief Medical Officer | 12/05/2019 | 14,880 |
Paolini John F. | SVP & Chief Medical Officer | 10/07/2019 | 18,600 |
Flynn James E | 10% Owner | 05/29/2018 | 15,996,834 |
Cormorant Asset Management, LP | 10% Owner | 05/29/2018 | 1,249,992 |
BAKER BROS. ADVISORS LP | Director | 05/29/2018 | 54,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,180,588 | 0.00142% | 2% | Other |
BAKER BROS. ADVISORS LP | 2,809,577 | 0.56% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 699,613 | 0.00128% | 6.07% | Other |
HHLR ADVISORS, LTD. | 3,879,426 | 1.51% | 455.20% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 661,715 | 0.14% | 31.36% | Growth |
AQR CAPITAL MANAGEMENT LLC | 228,045 | 0.00753% | -29.52% | Other |
D. E. SHAW & CO., INC. | 304,605 | 0.00467% | -4.07% | Other |
UBS OCONNOR LLC | 100,722 | 0.13% | -5.36% | Value |
ALPS ADVISORS INC | 41,896 | 0.00578% | -41.08% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 46,289 | 0.00152% | New | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View